WallStSmart

Lichen China Limited Class A Ordinary Shares (LICN)vsRelx PLC ADR (RELX)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Relx PLC ADR generates 39544% more annual revenue ($9.72B vs $24.52M). RELX leads profitability with a 23.3% profit margin vs -89.6%. RELX earns a higher WallStSmart Score of 64/100 (C+).

LICN

Avoid

29

out of 100

Grade: F

Growth: 2.0Profit: 2.0Value: 5.0Quality: 8.5
Piotroski: 2/9Altman Z: 9.00

RELX

Buy

64

out of 100

Grade: C+

Growth: 5.3Profit: 9.0Value: 7.3Quality: 3.8
Piotroski: 5/9
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for LICN.

RELXUndervalued (+59.6%)

Margin of Safety

+59.6%

Fair Value

$71.30

Current Price

$36.62

$34.68 discount

UndervaluedFair: $71.30Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

LICN3 strengths · Avg: 10.0/10
Price/BookValuation
0.3x10/10

Reasonable price relative to book value

Debt/EquityHealth
0.0110/10

Conservative balance sheet, low leverage

Altman Z-ScoreHealth
9.0010/10

Safe zone — low bankruptcy risk

RELX6 strengths · Avg: 9.0/10
Return on EquityProfitability
169.0%10/10

Every $100 of equity generates 169 in profit

Operating MarginProfitability
32.0%10/10

Strong operational efficiency at 32.0%

Market CapQuality
$65.96B9/10

Large-cap with strong market position

Profit MarginProfitability
23.3%9/10

Keeps 23 of every $100 in revenue as profit

EPS GrowthGrowth
24.3%8/10

Earnings expanding 24.3% YoY

Free Cash FlowQuality
$1.48B8/10

Generating 1.5B in free cash flow

Areas to Watch

LICN4 concerns · Avg: 2.5/10
Market CapQuality
$19.56M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Return on EquityProfitability
-39.8%2/10

ROE of -39.8% — below average capital efficiency

Revenue GrowthGrowth
-56.1%2/10

Revenue declined 56.1%

RELX3 concerns · Avg: 2.3/10
Revenue GrowthGrowth
2.7%4/10

2.7% revenue growth

Price/BookValuation
83.2x2/10

Trading at 83.2x book value

Debt/EquityHealth
3.101/10

Elevated debt levels

Comparative Analysis Report

WallStSmart Research

Bull Case : LICN

The strongest argument for LICN centers on Price/Book, Debt/Equity, Altman Z-Score.

Bull Case : RELX

The strongest argument for RELX centers on Return on Equity, Operating Margin, Market Cap. Profitability is solid with margins at 23.3% and operating margin at 32.0%. PEG of 1.40 suggests the stock is reasonably priced for its growth.

Bear Case : LICN

The primary concerns for LICN are Market Cap, Piotroski F-Score, Return on Equity.

Bear Case : RELX

The primary concerns for RELX are Revenue Growth, Price/Book, Debt/Equity. Debt-to-equity of 3.10 is elevated, increasing financial risk.

Key Dynamics to Monitor

LICN profiles as a turnaround stock while RELX is a value play — different risk/reward profiles.

RELX carries more volatility with a beta of 0.26 — expect wider price swings.

RELX is growing revenue faster at 2.7% — sustainability is the question.

RELX generates stronger free cash flow (1.5B), providing more financial flexibility.

Bottom Line

RELX scores higher overall (64/100 vs 29/100), backed by strong 23.3% margins. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Lichen China Limited Class A Ordinary Shares

INDUSTRIALS · SPECIALTY BUSINESS SERVICES · USA

Lichen China Limited, an investment holding company, provides financial and taxation, education support, and software and maintenance services in the People's Republic of China. The company is headquartered in Jinjiang, China.

Relx PLC ADR

INDUSTRIALS · SPECIALTY BUSINESS SERVICES · USA

RELX PLC provides information-based decision-making and analysis tools for professional and commercial clients in North America, Europe, and internationally. The company is headquartered in London, the United Kingdom.

Visit Website →

Want to dig deeper into these stocks?